Substituted 3-amino biaryl propionic acids as potent VLA-4 antagonists

被引：8
|
作者：
Kopka, IE
Lin, LS
Mumford, RA
Lanza, T
Magriotis, PA
Young, D
DeLaszlo, SE
MacCoss, M
Mills, SG
Van Riper, G
McCauley, E
Lyons, K
Vincent, S
Egger, LA
Kidambi, U
Stearns, R
Colletti, A
Teffera, Y
Tong, S
Owens, K
Levorse, D
Schmidt, JA
Hagmann, WK
机构：
[1] Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA
[2] Merck Res Labs, Dept Inflammat & Rheumatol Res, Rahway, NJ 07065 USA
[3] Merck Res Labs, Dept Drug Metab, Rahway, NJ 07065 USA
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2002年 / 12卷 / 17期
关键词：
D O I：
10.1016/S0960-894X(02)00460-2
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
A series of substituted N-(3,5-dichlorobenzenesulfonyl)-(L)-prolyl- and (L)-azetidyl-beta-biaryl beta-alanine derivatives was prepared as selective and potent VLA-4 antagonists. The 2,6-dioxygenated biaryl substitution pattern is important for optimizing potency. Oral bioavailability was variable and may be a result of binding to circulating plasma proteins. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码：2415 / 2418
页数：4
相关论文
共 50 条
  • [1] The discovery of acylated β-amino acids as potent and orally bioavailable VLA-4 antagonists
    Lin, LS
    Kopka, IE
    Mumford, RA
    Magriotis, PA
    Lanza, T
    Durette, PL
    Kamenecka, T
    Young, DN
    de Laszlo, SE
    McCauley, E
    Van Riper, G
    Kidambi, U
    Egger, LA
    Tong, XC
    Lyons, K
    Vincent, S
    Stearns, R
    Colletti, A
    Teffera, Y
    Fenyk-Melody, J
    Schmidt, JA
    MacCoss, M
    Hagmann, WK
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (04) : 611 - 614
  • [2] Heterocycle-substituted proline dipeptides as potent VLA-4 antagonists
    Reger, Thomas S.
    Zunic, Jasmine
    Stock, Nicholas
    Wang, Bowei
    Smith, Nicholas D.
    Munoz, Benito
    Green, Mitchell D.
    Gardner, Michael F.
    James, Joyce P.
    Chen, Weichao
    Alves, Kenneth
    Si, Qian
    Treonze, Kelly M.
    Lingham, Russell B.
    Mumford, Richard A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (03) : 1173 - 1176
  • [3] 2,3-Diphenylpropionic acids as potent VLA-4 antagonists
    Hoshina, Y
    Ikegami, S
    Okuyama, A
    Fukui, H
    Inoguchi, K
    Maruyama, T
    Fujimoto, K
    Matsumura, Y
    Aoyama, A
    Harada, T
    Tanaka, H
    Nakamura, T
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (01) : 217 - 220
  • [4] VLA-4 antagonists: Potent inhibitors of lymphocyte migration
    Yang, GX
    Hagmann, WK
    MEDICINAL RESEARCH REVIEWS, 2003, 23 (03) : 369 - 392
  • [5] The discovery of sulfonylated dipeptides as potent VLA-4 antagonists
    Hagmann, WK
    Durette, PL
    Lanza, T
    Kevin, NJ
    de Laszlo, SE
    Kopka, HE
    Young, D
    Magriotis, PA
    Li, B
    Lin, LS
    Yang, G
    Kamenecka, T
    Chang, LL
    Wilson, J
    MacCoss, M
    Mills, SG
    Van Riper, G
    McCauley, E
    Egger, LA
    Kidambi, U
    Lyons, K
    Vincent, S
    Stearns, R
    Colletti, A
    Teffera, J
    Tong, S
    Fenyk-Melody, J
    Owens, K
    Levorse, D
    Kim, P
    Schmidt, JA
    Mumford, RA
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (20) : 2709 - 2713
  • [6] Substituted tetrahydrofuroyl-1-phenylalanine derivatives as potent and specific VLA-4 antagonists
    Doherty, GA
    Yang, GX
    Borges, E
    Chang, LL
    MacCoss, M
    Tong, S
    Kidambi, U
    Egger, LA
    McCauley, E
    Van Riper, G
    Mumford, RA
    Schmidt, JA
    Hagmann, WK
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (11) : 1501 - 1505
  • [7] VLA-4 antagonists
    Tilley, JW
    Sidduri, A
    DRUGS OF THE FUTURE, 2001, 26 (10) : 985 - 998
  • [8] Antagonists of VLA-4
    Holland, GW
    Biediger, RJ
    Vanderslice, P
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 37, 2002, 37 : 65 - 74
  • [9] VLA-4 antagonists
    Tilley, JW
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2002, 12 (07) : 991 - 1008
  • [10] The discovery of acylated β-amino acids as potent and orally bioavailable VLA-4 antagonists (vol 12, pg 611, 2002)
    Lin, LS
    Kopka, IE
    Mumford, RA
    Magriotis, PA
    Lanza, T
    Durette, PL
    Kamenecka, T
    Young, DN
    de Laszlo, SE
    McCauley, E
    Van Riper, G
    Kidambi, U
    Egger, LA
    Tong, XC
    Lyons, K
    Vincent, S
    Stearns, R
    Colletti, A
    Teffera, Y
    Fenyk-Melody, J
    Schmidt, JA
    MacCoss, M
    Hagmann, WK
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (12) : 1695 - 1695
12345